Unlike many generic database providers, we have the expertise in-house to work with our customers to solve specific business issues. Growthink Research's venture capital database, along with our own new services, is another milestone along this track that will help our customers in their decision-making and effectiveness.
Oxford Science Park, Oxford (PRWEB) May 21, 2008
PharmaVentures announced today an agreement with Growthink Research, the US-based market research firm, to distribute its Venture Capital database to customers in industry and academic institutions worldwide. Fintan Walton, PhD, PharmaVentures' Chief Executive Officer, says, "As experts in deals and alliances in the pharmaceutical and biotechnology sector, we have in-depth knowledge of the workflows and information needs of business development and licensing executives. Access to comprehensive and reliable financial data is vital, and we are delighted to have forged this partnership to complement our own proprietary PharmaDeals® v2 database."
Corey Lavinsky, CEO for Growthink Research adds, "In our work analyzing venture capital activity, we have carefully tracked over 8,800 US-based, venture-funded companies, many within the bioscience industry. Our data is an invaluable resource for companies looking to raise capital or to identify new clients. Working with PharmaVentures will help us target new markets internationally that have a strong and persistent demand for this high quality financial information."
The new agreement with Growthink Research, and PharmaVentures' rapid development of its PharmaDeals database, analytical services and customer services, underpins PharmaVentures' drive to provide information solutions to its customers in top pharmaceutical and biotechnology companies. Anne Vindenes Allen, PharmaDeals' Chief Operating Officer says, "Unlike many generic database providers, we have the expertise in-house to work with our customers to solve specific business issues. Growthink Research's venture capital database, along with our own new services, is another milestone along this track that will help our customers in their decision-making and effectiveness."
PharmaVentures (http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making. The Company's core business is the provision of tailored transaction advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals® range of publishing products that include databases, analysis tools, and reports. PharmaVentures is based in Oxford, UK, and employs over 35 people. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.
About Growthink Research
Growthink Research is a market research firm that specializes in tracking and analyzing venture captial activity. Its proprietary venture capital database has detailed information on over 8,800 U.S.-based, venture-funded companies, over 17,000 funding transactions and over 90,000 executives, directors and advisors. Companies seeking captial, venture capital firms, investment bankers, and service providers rely on Growthink Research to raise capital, identify and secure new clients, and gain competitive intelligence.
28 S. Venice Blvd.
Venice, CA 90291
To sign up for future press releases from PharmaVentures, please contact:
Oxford Science Park
Oxford, OX4 4GA
Tel: +44 (0) 1865 784 177
Fax: +44 (0) 1865 784 178
Web site: http://www.pharmaventures.com
PharmaDeals is a registered trade mark of PharmaVentures Ltd.